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A B S T R A C T
Background
Hip and knee replacement are some of the most frequently performed surgical procedures in
the world. Resurfacing of the hip and unicondylar knee replacement are increasingly being
used. There is relatively little evidence on their performance. To study performance of joint
replacement in England, we investigated revision rates in the first 3 y after hip or knee
replacement according to prosthesis type.
Methods and Findings
We linked records of the National Joint Registry for England and Wales and the Hospital
Episode Statistics for patients with a primary hip or knee replacement in the National Health
Service in England between April 2003 and September 2006. Hospital Episode Statistics records
of succeeding admissions were used to identify revisions for any reason. 76,576 patients with a
primary hip replacement and 80,697 with a primary knee replacement were included (51% of all
primary hip and knee replacements done in the English National Health Service). In hip
patients, 3-y revision rates were 0.9% (95% confidence interval [CI] 0.8%–1.1%) with cemented,
2.0% (1.7%–2.3%) with cementless, 1.5% (1.1%–2.0% CI) with ‘‘hybrid’’ prostheses, and 2.6%
(2.1%–3.1%) with hip resurfacing (p , 0.0001). Revision rates after hip resurfacing were
increased especially in women. In knee patients, 3-y revision rates were 1.4% (1.2%–1.5% CI)
with cemented, 1.5% (1.1%–2.1% CI) with cementless, and 2.8% (1.8%–4.5% CI) with
unicondylar prostheses (p , 0.0001). Revision rates after knee replacement strongly decreased
with age.
Interpretation
Overall, about one in 75 patients needed a revision of their prosthesis within 3 y. On the basis
of our data, consideration should be given to using hip resurfacing only in male patients and
unicondylar knee replacement only in elderly patients.
The Editors’ Summary of this article follows the references.
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Introduction
Total hip replacement was ﬁrst successfully performed in
1962 in the United Kingdom and approved for use in the
United States in 1969 [1,2]. Total knee replacement was
introduced in its modern form in the early 1970s [3]. Since
then, these procedures have developed at an astonishing pace
and they are now among the most frequently performed
major surgical procedures in the world. In 2006, about
160,000 total hip and knee replacement procedures were
carried out in England and Wales and about 500,000 in the
United States [4,5].
A large number of different designs of hip and knee
prostheses have been developed and introduced on the
market. For example in England and Wales in 2006, at least
155 different brands of acetabular cups and 176 different
brands of femoral stems were used for hip replacement and
86 different prosthesis brands for knee replacement [4]. It can
be expected that these numbers will continue to increase
both as a result of new suppliers entering the market and new
brands being introduced by existing suppliers. These pros-
thesis brands are most often grouped according to the
method of ﬁxation of the components into cemented and
cementless prostheses. Other types are metal-on-metal
resurfacing of the hip and unicondylar knee replacement.
Metal-on-metal resurfacing of the hip has been developed
as an alternative procedure that conserves femoral bone and
only replaces the surface of the joint [6]. Resurfacing in its
modern form was introduced in the mid-1990s as an
alternative solution especially for physically active patients
[7]. In this procedure, the femur is ‘‘resurfaced’’ with a
hemispherical metal component and the femoral head and
neck are not removed. The acetabulum is replaced just as in a
total hip replacement. It is advocated that a revision of a
modern resurfacing procedure is less problematic in terms of
blood loss, operation time, and functional results than a
revision of a cemented or cementless prosthesis, which is an
advantage in young patients who are likely to outlive the
lifespan of their hip prosthesis. However, resurfacing is the
topic of much debate and some argue that its beneﬁts have
only been demonstrated in specialist centres and in selected
groups of patients [8].
The unicondylar knee replacement was originally intro-
duced in the mid-1980s as a procedure for patients with joint
damage that is limited to either the medial or lateral
compartment of the knee [9]. In this procedure, only the
damaged knee compartment is replaced. They are increas-
ingly being used as a result of both continuing improvements
in its design and the gradual development of minimally
invasive surgery. The indications for unicondylar prostheses
remain to be deﬁned. Some studies show higher revision rates
for this type of prosthesis than for total knee replacement,
whereas others show rates that are similar [10,11].
There is relatively little high-quality evidence on the
performance of the different prosthesis types available for
hip and knee replacement and even less on the performance
of individual brands. In a number of countries, national
registries were established to ﬁll this gap and to identify
poorly performing prostheses as early as possible after their
introduction on the market [12–18]. These national registries
demonstrate that overall revision rates after primary hip and
knee replacements are declining, which demonstrates the
remarkable success of a rather unsystematic process of
innovation lacking formal evaluation.
The National Joint Registry (NJR) for England and Wales
was established in April 2003 to provide patients, healthcare
professionals, regulators, and suppliers with timely evidence
on the performance of prosthesis brands [19,20]. It collects
information that is available immediately after surgery on the
characteristics of the patients including the indication for
surgery, the prostheses that are implanted, and the surgical
procedures used.
The NJR covers a population that is considerably larger
than any of the existing national joint registries (53.7 million
in 2006), which puts it in a unique position to provide
information on large numbers of patients who have recently
undergone a joint replacement. The emphasis on replace-
ments that took place in recent years is important because of
the observed decline in revision rates. The NJR can
furthermore achieve near complete follow-up through link-
age with the Hospital Episode Statistics database (HES) that
contains records of all admissions to National Health Service
(NHS) hospitals in England [21]. Through the linkage of NJR
and HES records, we were able to beneﬁt from the detailed
clinical information available in the NJR and the complete-
ness of follow-up through HES.
We considered revision rates for any reason in the ﬁrst 3 y
after primary hip and knee replacement as a measure of
performance. We investigated how these rates differed
according to prosthesis type and we gave special attention
to revision rates after hip resurfacing and unicondylar knee
replacement.
Methods
The NJR aims to collect data on all hip and knee
replacements in England and Wales. Candidates for inclusion
are patients who undergo a cemented, cementless, or
‘‘hybrid’’ total hip replacement or hip resurfacing, those
who undergo a total knee replacement, unicondylar replace-
ment, or patello-femoral replacement, and those who had a
revision of any of these procedures. Hybrid hip prostheses
have one cemented and one cementless component. Further
information can be found in the NJR 4th Annual Report [4].
We considered all 170,410 NJR records on primary hip
procedures and 167,498 on primary knee procedures carried
out between April 1, 2003 and September 30, 2006 (Figure 1).
A revision for any reason was used as outcome. Revisions
were identiﬁed through linkage with the HES database. We
did not use the NJR database to identify revisions, because
incomplete case ascertainment and missing patient identi-
ﬁers in the NJR would have led to considerable under-
estimation. The HES database contains routinely collected
records on admissions of patients treated in England in NHS
hospitals, in NHS treatment centres, as well as of those
treated in independent hospitals and independent sector
treatment centres with NHS funding [21]. The HES database
also contains date of death through linkage with the mortality
records of the Ofﬁce for National Statistics. Procedures are
coded according to the Ofﬁce of Population, Censuses and
Surveys Classiﬁcation of Surgical Operations and Procedures,
4th Revision (OPCS-4) [22]. Admissions for primary hip
replacements were identiﬁed in HES if the ﬁrst procedure
ﬁeld contained the codes W371 (primary total prosthetic
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replacement of hip joint using cement), W381 (primary total
prosthetic replacement of hip joint not using cement), W391
(primary total prosthetic replacement of hip joint not
elsewhere classiﬁed), and W581 (primary resurfacing arthro-
plasty of joint) in combination with Z843 (hip joint).
Admissions for primary knee replacement were identiﬁed
if the ﬁrst procedure ﬁeld contained the codes W401
(primary total prosthetic replacement of knee joint using
cement), W411 (primary total prosthetic replacement of knee
joint not using cement), W421 (primary total prosthetic
replacement of knee joint not elsewhere classiﬁed), W581
(primary resurfacing arthroplasty) in combination with Z846
(knee joint), and W521 (primary prosthetic replacement of
articulation of bone using cement not elsewhere classiﬁed).
The HES database contained 160,035 records of primary hip
procedures and 167,522 primary knee procedures (Figure 1).
Linkage of NJR records and HES records was carried out
according to ﬁve hierarchical linkage criteria: (1) local
hospital number and NHS Trust code; (2) NHS number and
NHS Trust code; (3) NHS number only; (4) patient date of
birth, sex, and NHS Trust code; and (5) patient date of birth
and NHS Trust code. Linkage was considered to be successful
if both the NJR and the HES record described a primary hip
replacement or a primary knee replacement and if the date of
the joint replacement according to the NJR was within the
start and end dates of the episode (i.e., the period that an
admitted patient is under the care of a consultant) according
to HES. A number of patients had undergone bilateral
primary hip or primary knee procedures on different dates.
In such cases, only the earliest primary procedure was
retained in the linked database to avoid including the same
patient twice.
For each patient with a linked primary procedure, all
hospital admissions recorded in HES succeeding the primary
procedure were identiﬁed on the basis of a unique patient
identiﬁer available in HES (HESID), which is based on the
Figure 1. Linkage of NJR with the HES Database
doi:10.1371/journal.pmed.0050179.g001
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patients’ sex, date of birth, and NHS number or in case NHS
number was unavailable on sex, date of birth, postcode, and
local hospital number. From these succeeding admissions, the
ﬁrst revision that occurred on the same side as the primary
was selected. Where the side of the primary or the revision
was not recorded, the ﬁrst revision that occurred after the
primary procedure was assumed to be a revision of that
primary procedure.
Hip revision procedures were identiﬁed using the OPCS-4
procedure codes W373 (revision of total prosthetic replace-
ment of hip joint using cement), W383 (revision of total
prosthetic replacement of hip joint not using cement), W393
(revision of total prosthetic replacement of hip joint not
elsewhere classiﬁed), W372 (conversion to total prosthetic
replacement of hip joint using cement), W382 (conversion to
total prosthetic replacement of hip joint not using cement),
W392 (conversion to total prosthetic replacement of hip joint
not elsewhere classiﬁed), W394 (attention to total prosthetic
replacement of hip joint not elsewhere classiﬁed) in
combination with Y032 (renewal of prosthesis in organ not
otherwise classiﬁed), and W582 (revision of resurfacing
arthroplasty of joint) in combination with Z843 (hip joint)
[23,24].
Knee revision procedures were identiﬁed using the codes
W403 (revision of total prosthetic replacement of knee joint
using cement), W413 (revision of total prosthetic replacement
of knee joint not using cement), W423 (revision of total
prosthetic replacement of knee joint not elsewhere classiﬁed),
W402 (conversion to total prosthetic replacement of knee
joint using cement), W412 (conversion to total prosthetic
replacement of knee joint not using cement), W422 (con-
version to total prosthetic replacement of knee joint not
elsewhere classiﬁed), W424 (attention to total prosthetic
replacement of knee joint) in combination with Y032
(renewal of prosthesis in organ not otherwise classiﬁed),
and W582 (revision of resurfacing arthroplasty of joint) in
combination with Z846 (knee joint) [23,24].
Using the revisions identiﬁed in HES as described above,
revision rates were then estimated for the different prosthesis
types. Revision rates were estimated using the Kaplan-Meier
survival analysis method with time of death or September 30,
2006 as the end of follow-up. The nonparametric Peto-Peto-
Prentice test, a modiﬁcation of the log-rank test that gives
greater weight to observations made early in the course of
follow-up, was used to test whether revision rates over time
were equal among the different prosthesis types.
Multivariable Cox regression was used to estimate hazard
ratios for prosthesis type, age group, sex, and indication for
surgery as risk factors for revision [25]. In all models, age was
included as a categorical variable. Hazard ratios can be
considered as relative risks related to each risk factor with
adjustment for the other factors. The partial likelihood ratio
test was used to test whether risk factors had an effect on the
revision rates by comparing one by one the log likelihood of
models that did and did not contain these risk factors. The
partial likelihood ratio test was used in a similar way to test
for interaction by comparing models that did and did not
contain the interaction terms.
The proportional hazard assumption was assessed by
testing the interaction of log time from operation with
prosthesis type. We found p-values of 0.1 for hip prosthesis
type and 0.8 for knee prosthesis type, which indicates that we
can accept that the hazard functions of the different
prosthesis types are proportional for both hips and knees.
Stata software (version 9.2) was used in all analyses.
Results
Of the 327,557 primary hip or knee replacement proce-
dures carried out between April 1, 2003 and September 30,
2006 in the NHS in England according to the HES database,
167,076 (51%) could be linked to an NJR record (Figure 1).
The remaining records could not be linked because the NJR
records did not contain the necessary patient identiﬁers.
After removal of 9,803 records of the second joint replace-
ment in patients who had undergone bilateral primary hip or
knee replacements on different dates, 157,273 patients were
available for analysis (Tables 1 and 2).
Revision Rates after Hip Replacement
76,576 patients in the linked database had undergone a
primary hip replacement. Of these patients, 41,232 (54%) had
Table 1. Characteristics of Patients Who Had a Primary Hip Replacement
Category Characteristic Prosthesis Type
Total Hip Replacement
Using Cement
Total Hip Replacement
Not Using Cement
Hybrid Total Hip
Replacement
Hip
Resurfacing
Overall
n Percent n Percent n Percent n Percent n Percent
Age ,55 y 1,634 4 2,937 15 1,313 13 3,098 50 8,982 12
55–64 y 5,998 15 6,020 32 2,733 27 2,551 41 17,302 23
65–74 y 16,642 40 6,727 35 3,776 37 516 8 27,661 36
75þ y 16,957 41 3,338 18 2,298 23 37 ,1 22,630 29
Not recorded 1 — 0 — 0 — 0 — 1 —
Sex Female 26,512 64 10,840 57 5,969 59 2,359 38 45,680 60
Male 14,705 36 8,172 43 4,148 41 3,843 62 30,868 40
Not recorded 15 — 10 — 3 — 0 — 28 —
Indication for surgery Osteoarthritis 38,854 94 17,701 93 9,274 92 5,879 95 71,708 94
Other 2,378 6 1,321 7 846 8 323 5 4,868 6
Total 41,232 — 19,022 — 10,120 — 6,202 — 76,576 —
doi:10.1371/journal.pmed.0050179.t001
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received a cemented prosthesis, 19,022 (25%) had received a
cementless prosthesis, 10,120 (13%) had received a hybrid
prosthesis, and 6,202 (8%) had undergone resurfacing (Table
1). The age and sex of the patients and type of prosthesis used
were strongly associated. For example, 91% of the patients
who underwent resurfacing were younger than 65 y and
about two-thirds were men, whereas 81% of those who
received a cemented prosthesis were 65 y or older and about
two-thirds were women. Overall, 94% of patients who
underwent a hip replacement because of osteoarthritis and
this percentage was similar across the prosthesis groups.
The overall revision rate following primary hip replace-
ment was 0.7% (95% conﬁdence interval [CI] 0.6%–0.7%) at 1
y and 1.4% (95% CI 1.2%–1.5%) at 3 y. Revision rates varied
according to the type of prosthesis used (p , 0.0001, Figure
2). The 3-y revision rate was lowest in patients who received a
cemented prosthesis (0.9%, 95% CI 0.8%–1.1%) and highest
after hip resurfacing (2.6%, 95% CI 2.1%–3.1%). The 3-y
revision rate was 2.0% (95% CI 1.7%–2.3%) in patients who
received a cementless prosthesis and 1.5% (95% CI 1.1%–
2.0%) in patients who received a hybrid. The differences in
revision rates among the procedure types were already
apparent within 3 mo of the primary procedure.
The pattern of revision rates according to hip prosthesis
Table 2. Characteristics of Patients Who Had a Primary Knee Replacement
Category Characteristic Prosthesis Type
Total Knee
Replacement
Using Cement
Total Knee
Replacement
Not Using Cement
Hybrid
Total Knee
Replacement
Unicondylar
Knee
Replacement
Patello-
Femoral
Replacement
Overall
n Percent n Percent n Percent n Percent n Percent n Percent
Age ,55 y 3,158 5 345 6 79 7 507 12 145 24 4,234 5
55–64 y 13,905 20 1,338 23 255 22 1,329 32 169 28 16,996 21
65–74 y 21,111 39 2,335 39 461 39 1,446 35 171 29 31,524 39
75þ y 24,728 36 1,887 32 383 32 828 20 115 19 27,941 35
Not recorded — — — — — — — — — — — —
Sex Female 40,163 58 3,247 55 668 57 2,067 50 446 74 46,591 58
Male 28,715 42 2,657 45 510 43 2,043 50 154 26 34,079 42
Not recorded 15 — 10 — 3 — 0 — 28 — — —
Indication for
surgery
Osteoarthritis 66,252 96 5,715 97 1,123 95 4,066 99 578 96 77,734 96
Other 2,652 4 190 3 55 5 44 1 22 4 2,963 4
Total 68,904 — 5,905 — 1,178 — 4,110 — 600 — 80,697 —
doi:10.1371/journal.pmed.0050179.t002
Figure 2. Survival Rate Estimates for Primary Hip Replacements
doi:10.1371/journal.pmed.0050179.g002
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type was related to the patients’ sex (p-value for interaction
between prosthesis type and sex: 0.001), but not to age (p-
value for interaction between prosthesis type and age: 0.3).
Therefore, we analysed the revision rates separately for men
and women. Revision rates were especially increased in
women who had undergone a resurfacing compared to those
who had received a cemented prosthesis (multivariable
hazard ratio 6.0, 95% CI 4.1–8.9; Table 3). Revision rates
were also increased in men who had undergone a resurfacing
but to a lesser extent (hazard ratio 2.8, 95% CI 1.9–4.0).
We also found that the revision rate was about twice as high
in patients who had had a hip replacement for other
indications than osteoarthritis. There was no evidence that
the revision rates varied according to the patients’ age.
Revision Rates after Knee Replacement
80,697 patients had undergone a primary knee replace-
ment. Of these patients, 68,904 (85%) had received a
cemented prosthesis, 5,905 (7%) a cementless prosthesis,
1,178 (1%) a hybrid, 4,110 (5%) a unicondylar prosthesis, and
600 (0.7%) a patello-femoral replacement (Table 2). In
contrast to patients who had a hip replacement, there was
no clear association between the age and sex of the patients
undergoing knee replacement and the type of prosthesis
used. The indication for surgery is osteoarthritis in 96% and
this percentage was similar in each prosthesis group.
The overall revision rate following primary knee replace-
ment was 0.4% (95% CI 0.3%–0.4%) at 1 y and 1.4% (95% CI
1.3%–1.6%) at 3 y. Considering cemented, cementless, and
unicondylar prostheses only, we found that revision rates
varied according to the prosthesis type used (p , 0.0001,
Figure 3). The 3-y revision rate was highest in patients who
had received a unicondylar prosthesis (2.8%, 95% CI 1.8%–
4.5%). The revision rates in those who had a cemented or
cementless prosthesis were similar (1.4%, 95% CI 1.2%–1.5%
and 1.5%, 95% CI 1.1%–2.1%, respectively).
There was no evidence that the pattern of revision rates
according to the type of knee prosthesis type was related to
sex (p-value for interaction between prosthesis type and sex:
0.6) and there was only weak evidence that it was related to
age (p-value for interaction between prosthesis type and age:
0.09) The revision rates decreased strongly with age and were
low for all three types of prosthesis in older patients (Table 4).
Discussion
Revision rates in the ﬁrst 3 y after hip and knee replace-
ments carried out in the NHS in England since April 2003
were low. Overall, we found that about one in 75 patients
needed a revision of their joint replacement. Patients who
had a cemented hip or cemented knee prosthesis had the
lowest revision rates. The highest rates after hip replacement
were seen in patients who had undergone hip resurfacing and
the highest rates after knee replacement in patients who had
a unicondylar prosthesis. Revision rates after hip resurfacing
were especially high in women. It is essential to continue
following up these patients to assess whether these differ-
ences remain beyond the ﬁrst 3 y, because it has been shown
that risk factors for revision as well as reasons for revision
change with time after the joint replacement [26].
Methodological Limitations
The identiﬁcation of revisions of primary hip and knee
replacement within the HES database may have been
incomplete. The completeness of this identiﬁcation process
depends on the following two conditions. First, the revision
procedure must have been carried out in the NHS and not in
the independent sector. Further explorations within the NJR
database only indicated that more than 98% of the revisions
were carried out in the NHS. Second, the revisions must be
captured by the OPCS-4 codes in the HES database. Given
that deﬁciencies in these codes cannot be excluded, we need
to accept that the reported revision rates may be under-
estimates.
Another limitation is that we could only include 51% of the
primary procedures carried out in the NHS. This percentage
was low because the NJR only started in 2003 and case
ascertainment and the collection of patient identiﬁers
Table 3. Primary Hip Replacement: Revision Rates (%) and Multivariable Hazard Ratios (95% CIs) According to Prosthesis Type and
Patient Characteristics
Category Prosthesis Type
and Patient
Characteristics
Men Women
1-y Revision
Rate
3-y Revision
Rate
Hazard
Ratio
1-y Revision
Rate
3-y Revision
Rate
Hazard
Ratio
Prothesis type Cemented 0.5% (0.4%–0.6%) 1.1% (0.8%–1.5%) 1 0.3% (0.2%–0.4%) 0.8% (0.7%–1.0%) 1
Cementless 1.0% (0.8%–1.3%) 2.4% (1.9%–3.1%) 2.3 (1.7–3.1) 1.0% (0.8%–1.2%) 1.6% (1.3%–2.0%) 2.7 (2.1–3.6)
Hybrid 0.9% (0.6%–1.3%) 1.9% (1.3%–2.6%) 1.8 (1.3–2.6) 0.6% (0.4%–0.8%) 1.2% (0.7%–1.9%) 1.6 (1.1–2.2)
Resurfacing 1.5% (1.1%–2.5%) 1.9% (1.4%–2.5%) 2.8 (1.9–4.0) 1.9% (1.4%–2.6%) 3.7% (2.8%–5.0%) 6.0 (4.1– 8.9)
p-Value — — — ,0.0001 — — ,0.0001
Age ,55 y 0.9% (0.7%–1.3%) 1.7% (1.3%–2.3%) 1 0.8% (0.5%–1.1%) 1.8% (1.4%–2.5%) 1
55–64 y 1.0% (0.8%–1.2%) 1.9% (1.5%–2.5%) 1.3 (0.9–1.9) 0.9% (0.7%–1.1%) 1.7% (1.3%–2.1%) 1.4 (1.0–2.0)
65–74 y 0.7% (0.5%–0.9%) 1.6% (1.2%–2.0%) 1.2 (0.8–1.8) 0.5% (0.4%–0.6%) 1.0% (0.8%–1.4%) 1.2 (0.8–1.8)
75þ y 0.7% (0.5%–0.9%) 1.3% (0.9%–2.1%) 1.3 (0.8–2.0) 0.4% (0.3%–0.6%) 0.9% (0.7%–1.2%) 1.2 (0.–1.8)
p-Value — — — 0.5 — — 0.3
Indication for surgery Osteoarthritis 0.8% (0.7%–0.9%) 1.5% (1.3%–1.8%) 1 0.6% (0.5%–0.7% 1.1% (1.0%–1.3%) 1
Other 1.2% (0.8%–1.9%) 3.1% (1.9%–5.0%) 1.9 (1.3–2.8) 0.8% (0.5%–1.2%) 2.4% (1.5%–3.7%) 1.9 (1.3–2.6)
p-Value — — — 0.004 — — 0.0009
doi:10.1371/journal.pmed.0050179.t003
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(needed to link the NJR records with HES records) are
gradually improving. However, the differences in age, sex,
and indications for surgery between the linked and nonlinked
procedures were marginal (unpublished data). Furthermore,
and even more importantly, the overall revision rates
following the primary hip and knee replacements in the
NHS that could not be included was 1.5%, and the
corresponding ﬁgure following a primary knee replacement
was 1.6%. These revision rates are very similar to those
observed in patients who were included, which supports our
conclusion that the observed results are representative at a
national level.
The clinical characteristics of the patients and their joint
problem will partly determine the choice of prosthesis type.
For example, cemented prostheses are generally implanted in
older and less active patients whereas cementless prostheses
are used in the youngest and most active ones. Therefore, we
took differences in patient characteristics into account when
comparing revision rates according to prosthesis type by
carrying out multivariable regression analyses. However,
there was little overlap between the distribution of patients’
age and sex of some of the prosthesis types. As a consequence,
we have to accept that some of the adjusted differences in
revision rates according to prosthesis type are due to
Figure 3. Survival Rate Estimates for Primary Knee Replacements
doi:10.1371/journal.pmed.0050179.g003
Table 4. Primary Knee Replacement: Revision Rates (%) and Multivariable Hazard Ratios (95% Confidence Intervals) According to
Prosthesis Type and Patient Characteristics
Category Prosthesis Type and
Patient Characteristics
1-y Revision Rate 3-y Revision Rate Hazard Ratio
Prosthesis type Cemented 0.4% (0.3%–0.4%) 1.4% (1.2%–1.5%) 1
Cementless 0.4% (0.3%–0.6%) 1.5% (1.1%–2.1%) 1.2 (0.9–1.6)
Unicondylar 0.7% (0.5%–1.1%) 2.8% (1.8%–4.5%) 1.7 (1.2–2.2)
p-Value — — — 0.006
Age ,55 y 0.6% (0.4%–1.0%) 3.0% (2.1%–4.4%) 1
55–64 y 0.5% (0.4%–0.6%) 2.3% (1.9%–2.8%) 0.8 (0.6–1.1)
65–74 y 0.4% (0.3%–0 5%) 1.2% (1.0%–1.5%) 0.5 (0.4–0.7)
75þ y 0.3% (0.2%–0.4%) 1.0% (0.8%–1.2%) 0.4 (0.3–0.6)
p-Value — — — ,0.0001
Sex Men 0.5% (0.4%–0.6%) 1.8% (1.5%–2.1%) 1
Women 0.3% (0.3%–0.4%) 1.2% (1.0%–1.4%) 0.7 (0.6–0.8)
p-Value — — — 0.0001
Indication for surgery Osteoarthritis 0.4% (0.3%–0.4%) 1.4% (1.3%–1.6%) 1
Other 0.5% (0.3%–0.9%) 1.5% (0.8%–2.6%) 1.1 (0.7–1.7)
p-Value — — — 0.8
doi:10.1371/journal.pmed.0050179.t004
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differences in the age and sex distribution as well as to
clinical characteristics that were not included in the multi-
variable model.
It has been suggested that the results of hip resurfacing and
unicondylar knee replacement strongly depend on the
surgeons’ experience with this technique [27,28]. A possible
explanation for the increased revision rates after these
procedures is that some surgeons who operated on patients
included in our study were still on a ‘‘learning curve.’’
However, we compared 1-y revision rates in patients who
received these prostheses in 2003, in 2004, and in 2005 or
2006 and did not ﬁnd evidence that the revision rates
decreased with time (1.3%, 1.3%, and 1.9% after hip
resurfacing and 0.6%, 0.6%, and 0.9% after unicondylar
knee replacement, respectively; p-values for both prostheses,
0.3).
Comparison with Other National Registries
A number of national registries have published quantita-
tive ﬁgures on revision rates in patients who had a hip and
knee replacement since 2000 (Table 5) [14–17]. The revision
rates observed in Norway and Australia are distinctly higher
than those observed in England, whereas those observed in
New Zealand are very similar. There are several possible
explanations for these differences. First, the completeness of
the identiﬁcation of revisions might be higher in Norway and
Australia than in England and New Zealand. Second, the
deﬁnitions of what constitutes a revision may differ between
the registries. For example, the NJR explicitly excludes re-
Table 5. Hip and Knee Revision Rates (95% CIs) in Other National Registries
Replace-
ment
Registry Prosthesis Type Time Period n 1 y 3 y Definition of Revision
Hip Norwegian Cemented 2000–2005 — — 1.8% Exchange or removal of femur, femoral
head, acetabulum, all components, or
complete arthrodesis.
Cementless 2000–2005 — — 2.6%
Australian Cemented 1999–2005 12,494 1.11% (0.93%–1.32%) 2.14% (1.87%–2.46%) Revision procedures are categorised as
major or minor. A major revision
involves removal and/or replacement of
either femoral stem or acetabular cup
or shell. A minor revision is a revision
where a major component has not been
removed or replaced. Examples of this
include exchange of femoral head and
or acetabular insert.
Cementless 1999–2005 42,937 1.71% (1.58%–1.84%) 2.79% (2.61%–2.98%)
Hybrid 1999–2005 29,441 1.45% (1.32%–1.60%) 2.38% (2.18%–2.59%)
Resurfacing 1999–2005 7,205 1.98% (1.67%–2.35%) 3.12% (2.67%–3.64%)
New Zealand All primary hips 1999–2005 35,998 0.3% () 1.2% () A revision is a new operation in a
previously replaced hip joint during
which one of the components are
exchanged, removed, manipulated, or
added. It includes excision arthroplasty
and amputation, but not a soft tissue
procedure.
Knee Swedish Total knee replacement
of osteoarthritis
1995–2004 48,838 0.81% (0.73%–0.90%) 2.36% (2.21%–2.55%) Revisions are defined as removal,
addition, and exchange of components.
Re-operations such as lavage or
synovectomy are not registered as
revisions if some part (typically a
polyethylene inlay) has not been
exchanged/removed during the
operation.
Total knee replacement
for rheumatoid arthritis
1995–2004 4,130 0.83% (0.59%–1.16%) 2.53% (2.06%–3.17%)
Unicondylar knee
replacement
of osteoarthritis
1995–2004 9,755 1.46% (1.23%–1.73%) 4.95% (4.5%–5.49%)
Australian Total knee replacement 1999–2005 107,802 1.05% (0.99%–1.12%) 2.84% (2.71%–2.96%) Revision procedures are categorised as
major or minor. A major revision involves
the removal and/or replacement of a
major component. This is defined (with
the exception of the patella) as a
component that interfaces with bone i.e.,
either the femoral and/or tibial
component. A minor revision is a revision
where a major component has not been
removed or replaced. Examples of this
include patella replacement, tibial insert
exchange, or both.
Unicondylar knee
replacement
1999–2005 18,398 2.37% (2.15%–2.62%) 6.24% (5.83%–6.69%)
New Zealand All primary knees 1999–2005 23,565 0.3% () 1.7% () Revision is defined as a new operation in
a previously replaced knee joint during
which one or more of the components
are exchanged, removed, manipulated, or
added. It includes arthrodesis or
amputation, but not a soft tissue
procedure.
doi:10.1371/journal.pmed.0050179.t005
PLoS Medicine | www.plosmedicine.org September 2008 | Volume 5 | Issue 9 | e1791405
Revisions after Hip and Knee Replacement
operations other than revisions [29], whereas the Australian
registry explicitly includes minor revisions (revisions that do
not include the removal of a component that interfaces with
bone with the exception of the patella) [15]. Third, data
validation procedures in some of these registries that check
the completeness of the reporting of revisions may lead to
selective inclusion of patients who had a revision, which may
lead to overestimates of the revision rate. In our analyses, we
aimed to avoid this bias by only considering revisions that
had a record of the primary replacement in the linked NJR-
HES database. Before we can come to any conclusions on
international differences in revision rates and in turn on the
quality of joint replacement care, these possible methodo-
logical explanations need to be explored in more detail.
Hip Resurfacing
The National Institute for Health and Clinical Excellence
(NICE) recommended in 2002 that hip resurfacing should be
considered as an option for patients with advanced hip
disease who are likely to live longer than the expected
lifespan of a conventional joint prosthesis [30]. Since then,
more evidence has become available, and resurfacing was also
approved for use in the United States in 2006 [7,15,31]. Our
results on hip resurfacing, the most recent series to date large
enough to allow age and sex speciﬁc comparisons with other
prosthesis types, indicated that revision rates after resurfac-
ing are higher in women, conﬁrming ﬁndings of the
Australian joint registry [15]. On the basis of these data,
resurfacing seems to be more suited for male than for female
patients.
Unicondylar Knee Replacement
A recent systematic review found no differences in the
revision rates after unicondylar knee replacement and total
knee replacement, but this review was limited by the quality
and quantity of the available evidence [9]. We found higher
revision rates after unicondylar than after total knee replace-
ment, similar to other national registries [15,17,28]. However,
revision rates after knee replacement decreased strongly with
age and consequently in elderly patients the absolute differ-
ences in revision rates according to prosthesis types are small
[14,15].
Unicondylar knee replacement is often recommended
because it is thought to be linked to shorter hospital and
recovery periods, and to produce superior functional out-
comes [32,33]. However, in a sample from the NJR of 10,000
patients 1 y after their knee replacement in 2003, it was found
that patients with a unicondylar knee replacement were less
likely to be satisﬁed with their joint replacement than
patients with a cemented total knee replacement (odds ratio
0.6, 95% CI 0.4–0.8, based on multivariable regression) [34].
Given these results, further research is required that ideally
should include patient-reported outcomes to establish what
type of patients are the best candidates for unicondylar
replacements.
Cemented and Cementless Hip Prostheses
A recent meta-analysis compared revision rates after
cemented and cementless total hip replacement [35]. This
meta-analysis included 20 studies of which three were
randomised clinical trials. Considering revisions of either or
both components, this study suggested that results depended
on the age of the patients showing lower revision rates with
cemented than with cementless prostheses in patients of 55 y
and older and no difference in the younger ones. However,
we did not ﬁnd evidence for such an interaction between
prosthesis type and age.
Further Implications
The most up-to-date revision rates reported by the NJR and
other national registries should be used as benchmarks
against which the performance of new prosthesis designs
and brands can be compared. This would also imply that the
benchmark revision rate set by National Institute for Health
and Clinical Excellence (NICE) for hip prostheses, now set at
10% or less at 10 y [30], from which a 3-y benchmark of 3% is
derived [36], may have to be adjusted downwards.
Furthermore, our results demonstrate that linking clinical
and administrative databases has the potential to improve the
quality and completeness as well as the efﬁciency of national
data collection. Record linkage might also provide additional
data on physical activity levels, smoking, and alcohol use,
which would allow a study of the impact of lifestyle factors on
revision rates.
High-quality national registries allow immediate evaluation
of the outcome of the ongoing technological innovations of
orthopaedic practice [37]. They would also provide a
structure within which randomised controlled trials can be
designed and carried out to directly compare beneﬁts and
harms of the different prosthesis types and brands. An
important consideration is that all these comparisons should
contain enough patients that subgroup analyses according to
age and sex are possible. Ideally, national joint replacement
registries would harmonise their data collection procedures
and deﬁnitions so that results from different countries with
their different orthopaedic cultures can be truly compared
and pooled.
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Editors’ Summary
Background. Though records show attempts to replace a hip date back
to 1891, it was not till the 1960s before total hip replacements were
successfully performed, and the 1970s before total knee replacements
were carried out. These procedures are some of the most frequently
performed surgical operations, with a total of 160,00 total hip and knee
replacement procedures carried out in England and Wales and about half
a million in the US in 2006. Hip and knee replacements are most
commonly used as a treatment for severe arthritis once other
approaches, such as pain relief medications, have failed. A total hip
replacement involves replacing the head of the femur (the thigh bone)
with an artificial component, typically metal; the socket into which the
new femur head will insert is also replaced with artificial components. In
an alternative procedure, resurfacing, rather than replacing the entire
joint, the diseased surfaces are replaced with metal components. This
procedure may be better suited to patients with less severe disease, and
is also thought to result in quicker recovery. The techniques for hip and
knee replacement can also be divided into those where a cement is used
to position the metal implant into the bone (cemented) versus those
where cement is not used (cementless).
Why Was This Study Done? To date, little evidence has been available
to compare patient outcomes following hip or knee replacement with
the many different types of techniques and prostheses available.
National registries have been established in a number of countries to
try to collect data in order to build the evidence base for evaluating
different types of prosthesis. Specifically, it is important to find out if
there are any important differences in revision rates (how often the hip
replacement has to be re-done) following surgery using the different
techniques. In England and Wales, the National Joint Registry (NJR) has
collected data on patient characteristics, types of prostheses implanted,
and the type of surgical procedures used, since its initiation in April 2003.
What Did the Researchers Do and Find? The researchers linked the
records of the NJR and the Hospital Episode Statistics (HES) for patients
treated by the NHS in England who had undergone a primary hip and
knee replacement between April 2003 and September 2006. The HES
database contains records of all admissions to NHS hospitals in England,
and allowed the researchers to more accurately identify revisions of
procedures that were done on patients in the NJR database.
They identified 327,557 primary hip or knee replacement procedures
performed during that time period, but only 167,076 could be linked
between the two databases.
76,576 patients in the linked database had undergone a primary hip
replacement. The overall revision rate was 1.4% (95% confidence interval
[CI] 1.2%–1.5%) at 3 years, with the lowest revision rates experienced by
patients who had cemented prostheses. Women were found to have
higher revision rates after hip resurfacing, and the revision rate was
about twice as high in patients who had had a hip replacement for other
indications than osteoarthritis. A patient’s age did not appear to affect
revision rates after hip surgery.
80,697 patients in the linked database had undergone a primary knee
replacement. The overall revision rate was 1.4% (95% CI 1.3%–1.6%) at
three years, again with the lowest rates of replacement experienced by
patients who had cemented prostheses. Revision rates after knee
replacement strongly decreased with age.
What Do These Findings Mean? Overall, about one in 75 patients
required a revision of their joint replacement, which is considered low,
and cemented hip or knee prosthesis had the lowest revision rates. Post
hip replacement, the highest revision rate was in patients who had
undergone hip resurfacing, especially women. Following knee replace-
ment, the highest revision rate was in patients who had undergone
unicondylar prosthesis. However, in this study patients were only
followed up for three years after the initial knee replacement, and it’s
possible that different patterns regarding the success of these differing
techniques may emerge after longer follow-up. Importantly, this study
was entirely observational, and data were collected from patients who
had been managed according to routine clinical practice (rather than
being randomly assigned to different procedures). Substantial differ-
ences in the age and clinical characteristics of patients receiving the
different procedures were seen. As a result, it’s not possible to directly
draw conclusions on the relative benefits or harms of the different
procedures, but this study provides important benchmark data with
which to evaluate future performance of different procedures and types
of implant.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0050179.
 The website of the British Orthopaedic Association contains
information for patients and surgeons
 The website of the National Institute for Health and Clinical Excellence
contains guidance on hip prostheses
 Information is available from the US National Institutes of Health
(Medline) on hip replacement, including interactive tutorials and
information about rehabilitation and recovery
 Medline also provides similar resources for knee replacement
 The NHS provides information for patients on hip and knee replace-
ment, including questions patients might ask, real stories, and useful
links
 The National Joint Registry provides general information about joint
replacement, as well as allowing users to download statistics on the
data it has collected on the numbers of procedures carried out in the UK
PLoS Medicine | www.plosmedicine.org September 2008 | Volume 5 | Issue 9 | e1791408
Revisions after Hip and Knee Replacement
